An approach that’s bold
An approach that’s bold
An approach that’s bold
Driven by hope
Driven by hope
Driven by hope
Dedication that’s real
Dedication that’s real
Dedication that’s real

Innovative therapeutics that target
serious viral diseases

Assembly Bio is applying our passion, scientific ingenuity and deep knowledge of virology to pursue novel antivirals with the potential to change the paradigm for the treatment of serious diseases. Our ambitious and compassionate work has the potential to change lives.

Discover our pipeline
Scientific woman

Our two clinical candidates

for recurrent genital herpes are designed to address the serious consequences of this disease and provide significant innovation over current standard of care.

Learn more
rotating circle rotating circle

Our clinical candidates for chronic hepatitis D and chronic hepatitis B

aim to improve outcomes for individuals facing the significant burden associated with chronic infection.

Explore our programs

Passionate. Purpose driven. Patient focused.

Explore opportunities to join our team. We are collectively inspired by and committed to developing novel antivirals that improve the lives of people facing serious viral diseases.

Join us!
three scientific people
In the News
May 13, 2026
Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026
May 11, 2026
Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference
May 07, 2026
Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights
    rotating circle rotating circle